Shaun Stapleton
Consigliere Generale presso RENEURON GROUP PLC
Provenienza dei contatti di primo grado di Shaun Stapleton
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Shaun Stapleton tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| UNILEVER PLC | Household/Personal Care | Corporate Officer/Principal | |
| SAREUM HOLDINGS PLC | Miscellaneous | Chairman Director/Board Member | |
| Antisoma Research Ltd. | Corporate Officer/Principal General Counsel | ||
| TIGENIX NV | Medical Specialties | Director of Finance/CFO | |
| OXFORD BIOMEDICA PLC | Biotechnology | Public Communications Contact | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Excalibur Fund Managers Ltd.
 Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member Founder | |
| University of Cambridge | College/University | Undergraduate Degree Doctorate Degree | |
Unipath Ltd.
 Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on 2001-12-20 for $146.54 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PHYSIOMICS PLC | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| University of Leeds | College/University | Doctorate Degree | |
| University of London | College/University | Undergraduate Degree Graduate Degree | |
ReNeuron Ltd.
 ReNeuron Ltd. BiotechnologyHealth Technology ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| WEIFA ASA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| University of Bocconi | College/University | Doctorate Degree | |
| London Business School | College/University | Masters Business Admin Corporate Officer/Principal | |
| University of Hertfordshire | College/University | Undergraduate Degree | |
| CHINA MEDICAL SYSTEM HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| BANCO SANTANDER, S.A. | Major Banks | Corporate Officer/Principal | |
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director of Finance/CFO | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor | |
| Glaxo Group Research Ltd. | Corporate Officer/Principal | ||
| The University of Law Ltd. | College/University | Graduate Degree | |
Food & Drug Analytical Services Ltd.
 Food & Drug Analytical Services Ltd. Miscellaneous Commercial ServicesCommercial Services Food & Drug Analytical Services Ltd. provides pharmaceutical quality control testing services. Its services include raw material, product release, and stability testing, microbiology, and development services. The firm also offers analytical methodologies, ICH stability storage, development and validation services. The company was founded in 2004 and is headquartered in Nottingham, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Monica Healthcare Ltd.
 Monica Healthcare Ltd. Medical SpecialtiesHealth Technology Monica Healthcare Ltd. develops wearable devices that use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. It offers Monica AN24 is a small leadless device that accurately monitors FHR, MHR, and UC using abdominal ECG electrodes. The device also offers a wireless ambulatory monitoring solution for maternal-fetal monitoring during about and delivery and for the homecare setting. The company was founded by Carl William Barratt, Barrie Robert Hayes-Gill, Jean-François Piéri and Terence Ronald Paul Martin in May 2005 and is headquartered in Nottingham, the United Kingdom. | Medical Specialties | Chairman | |
Sareum Ltd.
 Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Drugstore Chains | Chairman | |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Pharmaceuticals: Major | Director/Board Member | |
Locate Bio Ltd.
 Locate Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
GlaxoSmithKline Services Unlimited
 GlaxoSmithKline Services Unlimited Pharmaceuticals: MajorHealth Technology Glaxosmithkline Services Unlimited Ltd. develops, manufactures and markets pharmaceutical products. The company was incorporated on March 23, 1972 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ReNeuron (UK) Ltd.
 ReNeuron (UK) Ltd. BiotechnologyHealth Technology Part of ReNeuron Group Plc, ReNeuron (UK) Ltd. engages in research and experimental development on biotechnology. The company is based in Bridgend, UK and was founded in 2000. | Biotechnology | Director/Board Member Director/Board Member | |
| REDX PHARMA PLC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Aquanima Management Consulting
 Aquanima Management Consulting Miscellaneous Commercial ServicesCommercial Services Aquanima Management Consulting provides management consulting services. The private company is based in Madrid, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Sensia SL | Director/Board Member | ||
Peel Hunt LLP
 Peel Hunt LLP Investment Banks/BrokersFinance Peel Hunt LLP is an independent securities brokerage firm headquartered in London, UK. The firm was founded in 1989 as a market liquidity provider to retail and institutional investors. They provide bespoke dealing and execution services for institutional asset managers, registrars, private client wealth managers and private banks. | Investment Banks/Brokers | Sales & Marketing | |
| BENEVOLENTAI | Biotechnology | Director of Finance/CFO |
Statistiche
Distribuzione geografica
| Regno Unito | 32 |
| Spagna | 6 |
| Belgio | 3 |
| Svizzera | 3 |
| Stati Uniti | 2 |
Settori
| Health Technology | 19 |
| Consumer Services | 9 |
| Commercial Services | 8 |
| Finance | 7 |
| Consumer Non-Durables | 2 |
Posizioni
| Director/Board Member | 122 |
| Corporate Officer/Principal | 51 |
| Chairman | 50 |
| Independent Dir/Board Member | 33 |
| Chief Tech/Sci/R&D Officer | 21 |
Contatti più connessi
| Insiders | |
|---|---|
| Iain Ross | 41 |
| Simon Cartmell | 39 |
| John Berriman | 24 |
| Paul Harper | 20 |
| Timothy Corn | 20 |
| Michael Owen | 20 |
| Martin Walton | 16 |
| Mark James Docherty | 14 |
| Olav Hellebø | 13 |
| Claudia D'Augusta | 12 |
| Richard Beckman | 12 |
| Barbara Staehelin | 10 |
| Michael Elliot Hunt | 8 |
| Nicholas Adams | 7 |
| Sharon Grimster | 6 |
- Borsa valori
- Insiders
- Shaun Stapleton
- Connessioni Società
